TYNTESFIELD MEDICAL GROUP
NAILSEA FAMILY PRACTICE, TOWER HOUSE MEDICAL CENTRE, STOCK WAY SOUTH, NAILSEA, BRISTOLHF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
Indicator | Year | Numerator | Denominator | Ratio | Centile |
---|---|---|---|---|---|
HF 4 | 2010 | 27 | 39 | 69.2% | |
HF 4 | 2011 | 34 | 45 | 75.6% | |
HF 4 | 2012 | 46 | 56 | 82.1% | |
HF 4 | 2013 | 45 | 59 | 76.3% | |
HF004 | 2014 | 24 | 29 | 82.8% | |
HF004 | 2015 | 28 | 31 | 90.3% | |
HF004 | 2016 | 38 | 44 | 86.4% | |
HF004 | 2017 | 40 | 46 | 87.0% | |
HF004 | 2018 | 102 | 117 | 87.2% | |
HF004 | 2019 | 102 | 121 | 84.3% | |
HF004 | 2020 | 111 | 129 | 86.0% | |
HF006 | 2021 | 125 | 134 | 93.3% | |
HF006 | 2022 | 135 | 140 | 96.4% | |
HF006 | 2023 | 149 | 152 | 98.0% |